156 related articles for article (PubMed ID: 21833474)
1. 5-Lipoxygenase contributes to the progression of hepatocellular carcinoma.
Xu XM; Deng JJ; Yuan GJ; Yang F; Guo HT; Xiang M; Ge W; Wu YG
Mol Med Rep; 2011; 4(6):1195-200. PubMed ID: 21833474
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 12-lipoxygenase reduces proliferation and induces apoptosis of hepatocellular carcinoma cells in vitro and in vivo.
Xu XM; Yuan GJ; Deng JJ; Guo HT; Xiang M; Yang F; Ge W; Chen SY
Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):193-202. PubMed ID: 22484589
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 5-lipoxygenase triggers apoptosis in pancreatic cancer cells.
Zhou GX; Ding XL; Wu SB; Zhang HF; Cao W; Qu LS; Zhang H
Oncol Rep; 2015 Feb; 33(2):661-8. PubMed ID: 25483364
[TBL] [Abstract][Full Text] [Related]
4. 5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9.
Tu XK; Yang WZ; Shi SS; Chen CM; Wang CH
Neurol Res; 2009 Oct; 31(8):848-52. PubMed ID: 19309543
[TBL] [Abstract][Full Text] [Related]
5. Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.
Collin M; Rossi A; Cuzzocrea S; Patel NS; Di Paola R; Hadley J; Collino M; Sautebin L; Thiemermann C
J Leukoc Biol; 2004 Nov; 76(5):961-70. PubMed ID: 15328337
[TBL] [Abstract][Full Text] [Related]
6. [5-lipoxygenase is involved in rotenone-induced injury in PC12 cells].
Zhang XY; Zhang LH; Li CT; Chen WJ; Zhao JB; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 40(2):150-5. PubMed ID: 21488210
[TBL] [Abstract][Full Text] [Related]
7. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
[TBL] [Abstract][Full Text] [Related]
8. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
Rui W; Xie L; Liu X; He S; Wu C; Zhang X; Zhang L; Yang Y
J Ethnopharmacol; 2014; 151(1):198-209. PubMed ID: 24247078
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 5-lipoxygenase represses neutrophils activation and activates apoptosis in pancreatic tissues during acute necrotizing pancreatitis.
Liao D; Qian B; Zhang Y; Wu K; Xu M
Biochem Biophys Res Commun; 2018 Mar; 498(1):79-85. PubMed ID: 29421656
[TBL] [Abstract][Full Text] [Related]
10. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
[TBL] [Abstract][Full Text] [Related]
11. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis.
Chen X; Wang S; Wu N; Sood S; Wang P; Jin Z; Beer DG; Giordano TJ; Lin Y; Shih WC; Lubet RA; Yang CS
Clin Cancer Res; 2004 Oct; 10(19):6703-9. PubMed ID: 15475461
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA
Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
[TBL] [Abstract][Full Text] [Related]
15. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma progression promoted by 5-lipoxygenase activity in CD163(+) tumor-associated macrophages.
Nosaka T; Murata Y; Takahashi K; Naito T; Ofuji K; Matsuda H; Ohtani M; Hiramatsu K; Imamura Y; Goi T; Nakamoto Y
Biomed Pharmacother; 2023 Jun; 162():114592. PubMed ID: 36966664
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of 5-lipoxygenase, zileuton, suppresses prostate cancer metastasis by upregulating E-cadherin and paxillin.
Meng Z; Cao R; Yang Z; Liu T; Wang Y; Wang X
Urology; 2013 Dec; 82(6):1452.e7-14. PubMed ID: 24295266
[TBL] [Abstract][Full Text] [Related]
19. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
[TBL] [Abstract][Full Text] [Related]
20. [Expression of 5-lipoxygenase in hippocampal CA1 neuronal damage following global cerebral ischemia in rats].
Chen W; Li C; Zhao J; Zhang X; Han H; Wei E; Zhang L
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 42(1):61-6. PubMed ID: 23505109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
